Current treatment of chronic heart failure in primary care; Still room for improvement

Journal of Evaluation in Clinical Practice

Volumn 16, Issue 3, 2010, Pages 644-650

  Bosch, Marije ^a   Wensing, Michel ^a   Bakx, J Carel ^a   Van Der Weijden, Trudy ^b   Hoes, Arno W ^c   Grol, Richard P T M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Heart failure; Primary health care; Quality of health care; Treatment

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; SPIRONOLACTONE;

AGED; ARTICLE; DISEASE SEVERITY; DRUG CHOICE; DRUG INDICATION; FEMALE; GENERAL PRACTICE; HEART FAILURE; HUMAN; LIFESTYLE MODIFICATION; MALE; NETHERLANDS; PATIENT COUNSELING; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINES AS TOPIC; HEART FAILURE; HUMANS; MALE; OBSERVATION; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE;

EID: 77952941520     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2010.01455.x     Document Type: Article

References (40)

1. Mosterd, A. Hoes, A. W. (2007) Clinical epidemiology of heart failure. Heart, 93, 1137 1146.
2. McMurray, J. J. V. Stewart, S. (2003) The burden of heart failure. European Heart Journal Supplements, 5 (I 3 13.
3. Shah, S. Gheorghiade, M. (2008) Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA, 300 (4 431 433.
4. McMurray, J. Swedberg, K. (2006) Treatment of chronic heart failure: a comparison between the major guidelines. European Heart Journal, 27 (15 1773 1777.
5. Hunt, S. A., Abraham, W. T., Chin, M. H., et al. (2005) ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation, 112 (12 E154 E235.
6. Rutten, F. H., Walma, E., Kruizinga, G., Bakx, H. Van Lieshout, J. (2005) NHG-Standaard Hartfalen, eerste herziening. Huisarts en Wetenschap, 48 (2 64 76.
7. Swedberg, K., Cleland, G., Dargie, H., et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). European Heart Journal, 26, 1115 1140. (Pubitemid 40839912)
8. Bodenheimer, T., Wagner, E. H. Grumbach, K. (2002) Improving primary care for patients with chronic illness. JAMA, 288 (14 1775 1779.
9. Hoes, A. W., Mosterd, A. Grobbee, D. E. (1998) An epidemic of heart failure? Recent evidence from Europe. European Heart Journal, 19 (Suppl. L L2 L9.
10. Hobbs, F. D. R., Korewicki, J., Cleland, J. G. F., Eastaugh, J. Freemantle, N. (2005) The diagnosis of heart failure in European primary care: the IMPROVEMENT Programme survey of perception and practice. European Heart Journal, 7 (5 768 779.
11. Cleland, J. G. F., Cohen-Solal, A., Aguilar, J. C., et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet, 360 (9346 1631 1639.
12. Rutten, F. H., Grobbee, D. E. Hoes, A. W. (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. European Journal of Heart Failure, 5 (3 337 344.
13. CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet, 353 (9146 9 13.
14. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 353 (9169 2001 2007.
15. Komajda, M., Lapuerta, P., Hermans, N., Gonzalez-Juanatey, J. R., Van Veldhuisen, D. J., Erdmann, E., Tavazzi, L., Poole-Wilson, P. Le Pen, C. (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. European Heart Journal, 26 (16 1653 1659.
16. Pont, L. G., van Gilst, W. H., Lok, D. J. A., Kragten, H. J. A. Haaijer-Ruskamp, F. M. (2003) The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. European Journal of Heart Failure, 5 (2 187 193.
17. Muntwyler, J., Cohen-Solal, A., Freemantle, N., Eastaugh, J., Cleland, J. G. Follath, F. (2004) Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. European Journal of Heart Failure, 6 (5 663 668.
18. Jaarsma, T., Haaijer-Ruskamp, F. M., Sturm, H. Van Veldhuisen, D. J. (2005) Management of heart failure in The Netherlands. European Journal of Heart Failure, 7 (3 371 375.
19. Bongers, F. J. M., Schellevis, F., Bakx, C., Van den Bosch, W. J. H. M. Van der Zee, J. (2006) Treatment of heart failure in Dutch general practice. BMC Family Practice, 7 (40 doi:10.1186/1471-2296-7-40.
20. Rutten, F. H., Grobbee, D. E. Hoes, A. W. (2003) Diagnosis and management of heart failure: a questionnaire among general practitioners and cardiologists. European Journal of Heart Failure, 5 (3 345 348.
21. Lainscak, M., Moullet, C., Schön, N. Tendera, M. (2007) Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience. International Journal of Cardiology, 122 (2 149 155.
22. Franciosa, J. A., Massie, B. M., Lukas, M. A., Nelson, J. J., Lottes, S., Abraham, W. T., Fowler, M., Gilbert, E. M. Greenberg, B. (2004) beta-Blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. American Heart Journal, 148 (4 718 726.
23. Krum, H., Hill, J., Fruhwald, F., Sharpe, C., Abraham, G., Zhu, J. R., Poy, C. Kragten, J. A. (2006) Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study. European Journal of Heart Failure, 8 (3 302 307.
24. Dobre, D., Van Veldhuisen, D. J., Mordenti, G., Vintila, M., Haaijer-Ruskamp, F. M., Coats, A. J. S., Poole-Wilson, P. A. Flather, M. D. (2007) Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. American Heart Journal, 154 (1 109 115.
25. Pitt, B., Poole-Wilson, P. A., Segal, R., et al. (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet, 355 (9215 1582 1587.
26. Komajda, M., Lutiger, B., Madeira, H., et al. (2004) Tolerability of carvedilol and ACE-inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF Evaluation). European Journal of Heart Failure, 6 (4 467 475.
27. Lloyd-Williams, F., Mair, F., Shiels, C., et al. (2003) Why are patients in clinical trials of heart failure not like those we see in everyday practice? Journal of Clinical Epidemiology, 56 (12 1157 1162.
28. van Weel, C. Schellevis, F. G. (2006) Comorbidity and guidelines: conflicting interests. Lancet, 367 (9510 550 551.
29. Lainscak, M., Cleland, J. G. F., Lenzen, M., Follath, F., Komajda, M. Swedberg, K. (2005) International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the Euro Heart Failure survey. European Heart Journal, 26, 281.
30. Higashi, T., Wenger, N. S., Adams, J. L., Fung, C., Roland, M., McGlynn, E. A., Reeves, D., Asch, S. M., Kerr, E. A. Shekelle, P. G. (2007) Relationship between number of medical conditions and quality of care. New England Journal of Medicine, 356 (24 2496 2504.
31. Luck, J., Peabody, J. W., Dresselhaus, T. R., Lee, M. Glassman, P. (2000) How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. American Journal of Medicine, 108 (8 642 649.
32. McDonald, K. (2005) Current guidelines in the management of chronic heart failure: practical issues in their application to the community population. European Journal of Heart Failure, 7 (3 317 321.
33. Zile, M. R., Baicu, C. F. Bonnema, D. D. (2005) Diastolic heart failure: definitions and terminology. Progress in Cardiovascular Diseases, 47 (5 307 313.
34. Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L. Wu, A. W. (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases - implications for pay for performance. JAMA, 294 (6 716 724.
35. Walter, L. C., Davidowitz, N. P., Heineken, P. A. Covinsky, K. E. (2004) Pitfalls of converting practice guidelines into quality measures - lessons learned from a VA performance measure. JAMA, 291 (20 2466 2470.
36. Störk, S., Hense, H., Zentgraf, C., Uebelacker, I., Jahns, R., Erlt, G. Angermann, C. E. (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. European Journal of Heart Failure, 10, 1236 1245.
37. Komajda, M., Hanon, O., Hochadel, M., et al. (2009) Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. European Heart Journal, 30, 478 486.
38. Coletta, A. P., Cleland, J. G. F., Freemantle, N. Clark, A. L. (2004) Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. European Journal of Heart Failure, 6 (5 673 676.
39. Clarke, K. W., Gray, D. Hampton, J. R. (1994) Evidence of inadequate investigation and treatment of patients with heart-failure. British Heart Journal, 71 (6 584 587.
40. Yu, D. S. F., Thompson, D. Lee, D. (2006) Disease management programmes for older people with heart failure: crucial characteristics with improve post-discharge outcomes. European Heart Journal, 27, 596 612.